Please use this identifier to cite or link to this item:
|Title:||Nuclear HMGB1 protects from nonalcoholic fatty liver disease through negative regulation of liver X receptor||Authors:||Personnaz, Jean
Iacovoni, Jason S.
Schwabe, Robert F.
|Keywords:||Science::Medicine||Issue Date:||2022||Source:||Personnaz, J., Piccolo, E., Dortignac, A., Iacovoni, J. S., Mariette, J., Rocher, V., Polizzi, A., Batut, A., Deleruyelle, S., Bourdens, L., Delos, O., Combes-Soia, L., Paccoud, R., Moreau, E., Martins, F., Clouaire, T., Benhamed, F., Montagner, A., Wahli, W., ...Pradère, J. (2022). Nuclear HMGB1 protects from nonalcoholic fatty liver disease through negative regulation of liver X receptor. Science Advances, 8(12), eabg9055-. https://dx.doi.org/10.1126/sciadv.abg9055||Journal:||Science Advances||Abstract:||Dysregulations of lipid metabolism in the liver may trigger steatosis progression, leading to potentially severe clinical consequences such as nonalcoholic fatty liver diseases (NAFLDs). Molecular mechanisms underlying liver lipogenesis are very complex and fine-tuned by chromatin dynamics and multiple key transcription factors. Here, we demonstrate that the nuclear factor HMGB1 acts as a strong repressor of liver lipogenesis. Mice with liver-specific Hmgb1 deficiency display exacerbated liver steatosis, while Hmgb1-overexpressing mice exhibited a protection from fatty liver progression when subjected to nutritional stress. Global transcriptome and functional analysis revealed that the deletion of Hmgb1 gene enhances LXRα and PPARγ activity. HMGB1 repression is not mediated through nucleosome landscape reorganization but rather via a preferential DNA occupation in a region carrying genes regulated by LXRα and PPARγ. Together, these findings suggest that hepatocellular HMGB1 protects from liver steatosis development. HMGB1 may constitute a new attractive option to therapeutically target the LXRα-PPARγ axis during NAFLD.||URI:||https://hdl.handle.net/10356/164369||ISSN:||2375-2548||DOI:||10.1126/sciadv.abg9055||Schools:||Lee Kong Chian School of Medicine (LKCMedicine)||Rights:||© 2022 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution License 4.0 (CC BY).||Fulltext Permission:||open||Fulltext Availability:||With Fulltext|
|Appears in Collections:||LKCMedicine Journal Articles|
Updated on Nov 25, 2023
Web of ScienceTM
Updated on Oct 28, 2023
Updated on Dec 2, 2023
Updated on Dec 2, 2023
Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.